[7] Packer M.(2020). SGLT2 Inhibitors produce cardiorenal benefits by promoting adaptive cellular reprogramming to induce a state of fasting mimicry: A paradigm shift in understanding their mechanism of action, Diabetes Care, 43(3), 508–511. https://doi.org/10.2337/dci19-0074 [8] Packer ...
Genitourinary Tract Infections in Patients Taking SGLT2 Inhibitors: JACC Review Topic of the Week. J Am Coll Cardiol. 2024;83(16):1568-1578. [2]国家心血管病中心,国家心血管病专家委员会心力衰竭专业委员会,中国医师协会心力衰竭专业委员会,《中...
2.Jan, B., Adriaan A, V., Sean P, C., et al., Impact of empagliflozin on decongestion in acute heart failure: the EMPULSE trial. Eur Heart J[J] 2022, 44(1). 3Kramer, C.K., Zinman, B., Sodium-Glucose Cotransport...
然而，SGLT2抑制剂在住院糖尿病患者中的使用及其对临床结局的影响研究仍然较少，且相关的临床指南和共识尚不明确。最近，美国糖尿病协会（ADA）官方期刊《Diabetes Care》6月刊发表的一项全国性队列研究《Association of Continued Use of SGLT2 Inhibitors From the Ambulatory to Inpatient Setting With Hospital Outcomes...
2.XieLingli,XiaWenfang.CharacteristicsandmolecularmechanismsthroughwhichSGLT2inhibitorsimprovemetabolicdiseases:Amechanismreview,(2022),https://doi.org/10.1016/j.lfs.2022.120543 3.朱超,邵华,詹莹,厉伟兰,柳亚敏.钠-葡萄糖2型共转运蛋白抑制剂的降糖外作用[C]//.2014年中国药学大会暨第十四届中国药师周论文集....
[11]. Hallow KM, Helmlinger G, Greasley PJ, McMurray JJV, Boulton DW. Why do SGLT2 inhibitors reduce heart failure hospitalization? A differential volume regulation hypothesis. Diabetes Obes Metab. 2018 Mar;20(3):479-487. doi: 10.1111/dom.13126. Epub 2017 Nov 15. PMID: 29024278. ...
SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials. The Lancet, doi.org/10.1016/S0140-632590-X [4] Lilly Diabetes Update at ADA. Retrieved August 20, 2019, from ...
[4]. Nuffield Department of Population Health Renal Studies Group, SGLT2 inhibitor Meta-Analysis Cardio-Renal Trialists' Consortium. Impact of diabetes on the effects of sodium glucose co-transporter-2 inhibitors on kidney outcomes: collaborative meta-analysis of large placebo- controlled trials[J]....
为患者带来更加全面、有效的健康管理方案。参考 Yokose C, McCormick N, Abhishek A, et al. The clinical benefits of sodium-glucose cotransporter type 2 inhibitors in people with gout. Nat Rev Rheumatol. 2024;20(4):216-231. doi:10.1038/s41584-024-01092-x #养生就是健康之道# ...